[1] WARKENTIN B, STAVREV P, STAVREVA N. A TCP-NTCP estimation module using DVHs and known radiobiological models and parameter sets. 2004(1). doi:10.1120/jacmp.26.149
[2] NAQA I EI, SUNEJA G, LINDSAY P E. Dose response explorer:an integrated open-source tool for exploring and modelling radiotherapy dose-volume outcome relationships. 2006(22). doi:10.1088/0031-9155/51/22/001
[3] BRAHME A. Which parameters of the dose distribution are best related to the radiation response of tumours and normal tissues?, 1994
[4] MOHAN R, MAGERAS G S, BALDWIN B. Clinically relevant optimization of 3D conformal treatments. 1992(4). doi:10.1118/1.596781
[5] KUTCHER G J, BURMAN C, BREWSTER L. Histogram reduction method for calculating complication probabilities for threedimensional treatment planning evaluations, 1991(1)
[6] KUTCHER G J, BURMAN C. Calculation of complication probability factors for non-uniform normal tissue radiation:the effective volume method. 1989(6). doi:10.1016/0360-3016(89)90972-3
[7] NIEMIERKO A. Reporting,and analyzing dose distributions:aconcept of equivalent uniform dose. 1997(1). doi:10.1118/1.598063
[8] NIEMIERKO A. A generalized concept of equivalent uniform dose (EUD) (abstract), 1999(6)
[9] SCHULTHEISS T E. Models in radiotherapy:volume effects. 1983(4). doi:10.1118/1.595312
[10] EMAMI B, LYMAN J, BROWN A. Tolerance of normal tissue to therapeutic irradiation, 1991(1)
[11] NIEMIERKO A. A unified model of tissue response to radiation (abstract), 1999(6)
[12] LYMAN J T. Complication probability as assessed from dose volume histograms. 1985(2). doi:10.2307/3576626
[13] WITHERS H R, TAYLOR J M G, MACIEJEWSKI B. Treatment volume and tissue tolerance. 1988(4). doi:10.1016/0360-3016(88)90098-3
[14] NIEMIERKO A, GOITEIN M. Modeling of normal tissue-response to radiation-the critical volume model. 1993(1). doi:10.1016/0360-3016(93)90156-P
[15] STAVREV P, STAVREVA N, NIEMIERKO A. Generalization of a model of tissue response to radiationbased on the idea of functional subunits and binomial statistics. 2001(5). doi:10.1088/0031-9155/46/5/312
[16] YORKE E D, JACKSON A, ROSENZWEIG K E. Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy. 2002(2). doi:10.1016/S0360-3016(2)02929-2
[17] WEBB S. The physics of conformal radiotherapy:advances in technology, 1997
[18] HALL E J, GIACCIA A J. Radiobiology for the radiologist, 2006
[19] ZAIDER M, MINERBO G N. Tumour control probability:a formulation applicable to any temporal protocol of dose delivery. 2000(2). doi:10.1088/0031-9155/45/2/303
[20] STAVREVA N A, STAVREV P V, WARKENTIN B. Investigating the effect of cell repopulation on the tumor response to fractionated external radiotherapy. 2003(5). doi:10.1118/1.1567735
[21] TUCKER S L, TAYLOR J M. Improved models of tumor cure, 1996(5)
[22] KENDAL W S. A closed-form description of tumor control with fractionated radiotherapy and repopulation, 1998(2)
[23] SACHS R K, HEIDENREICH W F, BRENNER D J. Dose timing in tumor radiotherapy:considerations of cell number stochasticity. 1996(2). doi:10.1016/S0025-5564(96)00128-9
[24] ZAIDER M, WUU C S. The combined effects of sublethal damage repair,cellular repopulation and redistribution in the mitotic cycle.I.Survival probabilities following exposure to radiation. 1996(4). doi:10.2307/3579067
[25] BARENDSEN G W. Differences among tissues with respect to iso-effect relations for fractionated irradiation, 1984(11)
[26] ADAC. Objectives and constraints in user guide:inverse planning and IMRT for PINNACLE3, 2002
[27] ALBER M. Normal tissue dose-effect models in biological dose optimization, 2007(4)
[28] WITHERS H R. Biological aspects of conformal therapy. 2000(5). doi:10.1080/028418600750013258 |
